This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q83882470
rdf:type
wikibase:Item
schema:description
scientific article published on 01 January 2011 наукова стаття, опублікована в січні 2011 im Jahr 2011 veröffentlichter wissenschaftlicher Artikel article scientifique (publié 2011) wetenschappelijk artikel artikull shkencor i botuar më 01 janar 2011 artículu científicu espublizáu en xineru de 2011
p:P577
wds:Q83882470-10ADE23B-258C-41A2-B03C-554D20159F48
wdt:P577
2011-01-01T00:00:00Z
p:P2093
wds:Q83882470-C5604CC7-2119-457C-BD42-5249D6AD33BD wds:Q83882470-31C3BC94-B4B7-44F2-BA75-A1B85EC58906
wdt:P2093
N V Orekhova P N Vlasov
rdfs:label
[The "cost-benefit" analysis of new antiepileptic drugs] [The "cost-benefit" analysis of new antiepileptic drugs] [The "cost-benefit" analysis of new antiepileptic drugs]
skos:prefLabel
[The "cost-benefit" analysis of new antiepileptic drugs] [The "cost-benefit" analysis of new antiepileptic drugs] [The "cost-benefit" analysis of new antiepileptic drugs]
schema:name
[The "cost-benefit" analysis of new antiepileptic drugs] [The "cost-benefit" analysis of new antiepileptic drugs] [The "cost-benefit" analysis of new antiepileptic drugs]
p:P1476
wds:Q83882470-CEA8E41C-D1E4-4E26-A16D-F194549A8444
wdt:P1476
[The "cost-benefit" analysis of new antiepileptic drugs]
p:P304
wds:Q83882470-0AE8F07E-3857-4F3D-AEC7-A8C8E9B6BCD8
wdt:P304
39-43
p:P31
wds:Q83882470-2ACDECC7-E75D-494D-9054-B6A5B7074708
wdt:P31
wd:Q13442814
p:P921
wds:Q83882470-3BEB2B97-5C03-4117-81F9-DAF3AE82E3F5
wdt:P921
wd:Q942582
p:P698
wds:Q83882470-ECEBA52D-0234-46CB-917B-BE9DBD49484B
wdtn:P698
n9:22500311
wdt:P698
22500311
p:P1433
wds:Q83882470-3AE2B4F5-E337-417D-ABA5-1E6BD44966B3
wdt:P1433
wd:Q4181935
p:P433
wds:Q83882470-1C19E8BD-7BB4-4907-8F12-36D36D3EE7FD
p:P478
wds:Q83882470-F3DB9F47-BBBF-48E0-9049-1A5178B83451
wdt:P433
10 Pt 1
wdt:P478
111